$4.33
0.338.25%
Last update: Nov 10, 4:01 PM
AN2 Therapeutics Inc
ANTXNASDAQ
The average analyst price target for AN2 Therapeutics is $5.40, 24.7% above the current price. Of 6 analysts, 4 rate it Buy and 2 Hold. Targets range from $2 to $9. The latest change came on Jul 20, 2026, when Guggenheim initiated coverage of AN2 Therapeutics with a Buy rating and a $9 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 6 Analysts
Rating Trend — Last 9 Months
